U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07387302) titled 'SLN12140 in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China' on Jan. 22.
Brief Summary: The goal of this clinical trial is to learn if drug SLN12140 works to treat Complement Inhibitor-Naive Subjects with Paroxysmal Nocturnal Hemoglobinuria in adults. It will also learn about the safety, pharmacokinetic characteristics, and dosing of drug SLN12140.
The study is divided into four phases: screening period, core treatment period, extended dosing period, and follow-up period, and includes two cohorts (Cohorts 1-2), with each cohort enrolling at least 5 treatment-naive adult PNH subjects for complement inhibito...